Dexmedetomidine and clonidine: From second- to first-line sedative agents in the critical care setting?

Journal of Intensive Care Medicine

Volumn 27, Issue 4, 2012, Pages 219-237

  Pichot, C ^a   Ghignone, M ^b   Quintin, L ^c  

^a Memorial Hospital   (France)

^b Critical Care Medicine   (United States)

^c UNIVERSITÉ DE LYON   (France)

Author keywords

clonidine; critical care medicine; dexmedetomidine; intensive care medicine; O2 consumption; respiratory drive; sedation; systolic function; vascular reactivity; weaning

Indexed keywords

AMINE; CLOMETHIAZOLE; CLONIDINE; DEXMEDETOMIDINE; FENTANYL; LORAZEPAM; MIDAZOLAM; PROPOFOL;

AIR CONDITIONING; AMNESIA; ARTIFICIAL VENTILATION; BRADYCARDIA; CARDIOVASCULAR RESPONSE; CENTRAL NERVOUS SYSTEM; DELIRIUM TREMENS; DIZZINESS; DOUBLE BLIND PROCEDURE; HEART ARRHYTHMIA; HEART LEFT VENTRICLE PERFORMANCE; HUMAN; HYPOTENSION; IMPEDANCE; INTENSIVE CARE; LOADING DRUG DOSE; LOW DRUG DOSE; MULTICENTER STUDY (TOPIC); NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY DISTRESS; REVIEW; SEDATION; SINGLE DRUG DOSE; SINUS ARREST; SYNCOPE; VASOMOTOR REFLEX;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ANIMALS; CARDIOVASCULAR PHYSIOLOGICAL PROCESSES; CLONIDINE; CRITICAL CARE; DEXMEDETOMIDINE; GASTROINTESTINAL TRACT; HUMANS; HYPNOTICS AND SEDATIVES; RESPIRATION;

EID: 84863585302     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066610396815     Document Type: Review

References (157)

1. Kollef MH, Levy NT, Ahrens TS, Schaiff R, Prentice D, Sherman G.. The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation. Chest. 1998 ; 114 (2). 541-548 (Pubitemid 28387536)
2. Kress JP, Pohlman AS, O'Connor MF, Hall JB.. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med. 2000 ; 342 (20). 1471-1477 (Pubitemid 30318270)
3. Knaus AE, Muthig V, Schickinger S, et al. Alpha2-adrenoceptor subtypes-unexpected functions for receptors and ligands derived from gene-targeted mouse models. Neurochem Int. 2007 ; 51 (5). 277-281 (Pubitemid 47374320)
4. Robertson D, Goldberg MR, Hollister AS, Wade D, Robertson RM.. Clonidine raises blood pressure in severe idiopathic orthostatic hypotension. Am J Med. 1983 ; 74 (2). 193-200 (Pubitemid 13192173)
5. Shehabi Y, Ruettimann U, Adamson H, Innes R, Ickeringill M.. Dexmedetomidine infusion for more than 24 hours in critically ill patients: sedative and cardiovascular effects. Intensive Care Med. 2004 ; 30 (12). 2188-2196 (Pubitemid 40174254)
6. Riker RR, Shehabi Y, Bokesch PM, et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. J Am Med Assoc. 2009 ; 301 (5). 489-499
7. Pandharipande PP, Pun B, Herr DI, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. J Am Med Assoc. 2007 ; 298 (22). 2644-2653 (Pubitemid 350254956)
8. Marwaha J, Aghajanian GK.. Relative potencies of alpha-1 and alpha-2 antagonists in the locus coeruleus, dorsal raphe and dorsal lateral geniculate nuclei: an electrophysiological study. J Pharmacol Exp Ther. 1982 ; 222 (2). 287-293 (Pubitemid 12047253)
9. Quintin L, Gonon F, Buda M, Ghignone M, Hilaire G, Pujol JF.. Clonidine modulates locus coeruleus metabolic hyperactivity induced by stress in behaving rats. Brain Res. 1986 ; 362: 366-369 (Pubitemid 16170178)
10. Quintin L, Ghignone M. Progress in Catecholamine Research. Part C: Clinical Aspects. (Proceedings of the Sixth International Catecholamine Symposium). Belmaker RH Sandler M Dahlstrom A, ed. New York: A. R. Liss ; 1988: 447-459.
11. Sun MK, Guyenet P.. Effect of clonidine and gamma-aminobutyric acid on the discharges of medullo-spinal sympathoexcitatory neurons in the rat. Brain Res. 1986 ; 368 (1). 1-17 (Pubitemid 16052304)
12. Quintin L, Ghignone M. Alpha-2 Adrenoceptor Agonists in Anaesthesia and Intensive Care. Scholz J Tonner PH, ed. London: Harcourt ; 2000: 347-368.
13. Toader E, Cividjian A, Rentero N, McAllen RM, Quintin L.. Cardioinhibitory actions of clonidine assessed by cardiac vagal motoneuron recordings. J Hypertension. 2008 ; 26: 1169-1180 (Pubitemid 351670509)
14. Sleight P, West MJ, Korner PI, Oliver JR, Chalmers JP, Robinson JL.. The action of clonidine on the baroreflex control of heart rate in conscious animals and man and on single aortic baroreceptor discharge in the rabbit. Arch Int Pharmacodynamy Ther. 1975 ; 214: 4-11
15. Saunier CF, Akaoka H, de La Chapelle B, et al. Activation of brain noradrenergic neurons during recovery from halothane anesthesia: persistence of phasic activation after clonidine. Anesthesiology. 1993 ; 79 (5). 1072-1082 (Pubitemid 23339067)
16. Aston-Jones G, Ennis M, Pieribone VA, Nickell WT, Shipley MT.. The brain nucleus coeruleus: restricted afferent control of a broad efferent network. Science. 1986 ; 234 (4777). 734-737 (Pubitemid 17184220)
17. Segal IS, Vickery RG, Walton JK, Doze VA, Maze M.. Dexmedetomidine diminishes halothane anesthetic requirements in rats through a postsynaptic alpha-2 adrenergic receptor. Anesthesiology. 1988 ; 69 (6). 818-823 (Pubitemid 19021625)
18. Kooner JS, Peart WS, Mathias CJ.. The haemodynamic and hormonal responses after clonidine occur independently of sedation in essential hypertension. Br J Clin Pharmacol. 1989 ; 28 (3). 249-255
19. Schmitt H. Handbook of Experimental Pharmacology. Gross F, ed. Berlin: Springer ; 1977: 299-396.
20. Hashimoto J, Chonan K, Aoki Y, et al. Therapeutic effects of evening administration of guanabenz and clonidine on morning hypertension: evaluation using home-based blood pressure measurements. J Hypertens. 2003 ; 21 (4). 805-811 (Pubitemid 36549677)
21. Onesti G, Bock KD, Heimsoth V, Kim KE, Merguet P.. Clonidine: a new antihypertensive agent. Am J Cardiol. 1971 ; 28 (1). 74-83
22. Wing LM, Reid JL, Davies DS, Dargie HJ, Dollery CT.. Apparent resistance to hypotensive effect of clonidine. Br Med J. 1977 ; 1 (6054). 136-138 (Pubitemid 8017309)
23. Miyazaki S, Uchida S, Mukai J, Nishihara K.. Clonidine effects on all-night human sleep: opposite action of low- and medium-dose clonidine on human NREM-REM sleep proportion. Psychiatry Clin Neurosci. 2004 ; 58 (2). 138-144 (Pubitemid 38470534)
24. Huupponen E, Maksimow A, Lapinlampi P, et al. Electroencephalogram spindle activity during dexmedetomidine sedation and physiological sleep. Acta Anaesthesiol Scand. 2008 ; 52 (2). 289-294
25. Metz G, Nebel B.. Clonidine in severe alcohol withdrawal delirium. Fortschr Med. 1983 ; 101 (26). 1260-1264 (Pubitemid 13030381)
26. Spies CD, Dubisz N, Neumann T, et al. Therapy of alcohol withdrawal syndrome in intensive care unit patients following trauma: results of a prospective, randomized trial. Crit Care Med. 1996 ; 24 (3). 414-422 (Pubitemid 26097833)
27. Bohrer H, Bach A, Layer M, Werming P.. Clonidine as a sedative adjunct in intensive care. Int Care Med. 1990 ; 16: 265-266 (Pubitemid 20191419)
28. Triltsch AE, Welte M, von HP, et al. Bispectral index-guided sedation with dexmedetomidine in intensive care: a prospective, randomized, double blind, placebo-controlled phase II study. Crit Care Med. 2002 ; 30 (5). 1007-1014 (Pubitemid 34508021)
29. Martin E, Ramsay G, Mantz J, Sum-Ping ST.. The role of the alpha-2 adrenoceptor agonist dexmedetomidine in postsurgical sedation in the intensive care unit. J Intensive Care Med. 2003 ; 18 (1). 29-41 (Pubitemid 44526587)
30. Chrysostomou C, Di FS, Manrique AM, et al. Use of dexmedetomidine in children after cardiac and thoracic surgery. Pediatr Crit Care Med. 2006 ; 7 (2). 126-131
31. Ruokonen E, Parviainen I, Jakob SM, et al. Dexmedetomidine versus propofol/midazolam for long-term sedation during mechanical ventilation. Intensive Care Med. 2009 ; 35 (2). 282-290
32. Gold MS, Redmond DE, Kleber HD.. Clonidine blocks acute opiate-withdrawal symptoms. Lancet. 1978 ; 2 (8090). 599-602 (Pubitemid 9009208)
33. Liatsi D, Tsapas B, Pampori S, Tsagourias M, Pneumatikos I, Matamis D.. Respiratory, metabolic and hemodynamic effects of clonidine in ventilated patients presenting with withdrawal syndrome. Intensive Care Med. 2009 ; 35 (2). 275-281
34. Freshwater-Turner D, Udy A, Lipman J, et al. Autonomic dysfunction in tetanus-what lessons can be learnt with specific reference to alpha-2 agonists?. Anaesthesia. 2007 ; 62 (10). 1066-1070 (Pubitemid 47399402)
35. Sutton DN, Tremlett MR, Woodcock TE, Nielsen MS.. Management of autonomic dysfunction in severe tetanus: the use of magnesium sulphate and clonidine. Intensive Care Med. 1990 ; 16 (2). 75-80 (Pubitemid 20277716)
36. Martin J, Parsch A, Franck M, Wernecke KD, Fischer M, Spies C.. Practice of sedation and analgesia in German intensive care units: results of a national survey. Crit Care. 2005 ; 9 (2). R117 - R123
37. Tonner PH, Weiler N, Paris A, Scholz J.. Sedation and analgesia in the intensive care unit. Curr Opin Anaesthesiol. 2003 ; 16 (2). 113-121 (Pubitemid 36521164)
38. Rubino AS, Onorati F, Caroleo S, et al. Impact of clonidine administration on delirium and related respiratory weaning after surgical correction of acute type-A aortic dissection: results of a pilot study. Interact Cardiovasc Thorac Surg. 2010 ; 10 (1). 58-62
39. Maldonado JR, Wysong A, van der Starre PJ, Block T, Miller C, Reitz BA.. Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery. Psychosomatics. 2009 ; 50 (3). 206-217
40. Venn RM, Bradshaw CJ, Spencer R, et al. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia. 1999 ; 54 (12). 1136-1142
41. Venn RM, Grounds RM.. Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions. Br J Anaesth. 2001 ; 87 (5). 684-690 (Pubitemid 33069556)
42. Venn RM, Hell J, Grounds RM.. Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care. 2000 ; 4 (5). 302-308
43. Tobias JD.. Dexmedetomidine: applications in pediatric critical care and pediatric anesthesiology. Pediatr Crit Care Med. 2007 ; 2007: 115-131 (Pubitemid 46568561)
44. Sauder P, Andreoletti M, Cambonie G, et al. Sedation and analgesia in intensive care. French Crit Care Soc. Ann Fr Anesth Reanim. 2008 ; 27: 541-551
45. Venn RM, Newman PJ, Grounds RM.. A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit. Intensive Care Med. 2003 ; 29: 201-207 (Pubitemid 36384409)
46. MacLaren R, Forrest LK, Kiser TH.. Adjunctive dexmedetomidine therapy in the intensive care unit: a retrospective assessment of impact on sedative and analgesic requirements, levels of sedation and analgesia, and ventilatory and hemodynamic parameters. Pharmacotherapy. 2007 ; 27 (3). 351-359 (Pubitemid 46327903)
47. Connor DF, Fletcher KE, Swanson JM.. A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1999 ; 38 (12). 1551-1559
48. Cohen DJ, Detlor J, Young JG, Shaywitz BA.. Clonidine ameliorates Gilles de la Tourette syndrome. Arch Gen Psychiatry. 1980 ; 37 (12). 1350-1357 (Pubitemid 11204073)
49. Freedman R, Kirch D, Bell J, et al. Clonidine treatment of schizophrenia. Double-blind comparison to placebo and neuroleptic drugs. Acta Psychiatry Scand. 1982 ; 65: 35-45 (Pubitemid 12179816)
50. McEntee WJ, Mair RG.. Memory enhancement in Korsakoff's psychosis by clonidine: further evidence for a noradrenergic deficit. Ann Neurol. 1980 ; 7: 466-470 (Pubitemid 10073127)
51. Akada S, Takeda S, Yoshida Y, et al. The efficacy of dexmedetomidine in patients with noninvasive ventilation: a preliminary study. Anesth Analg. 2008 ; 107 (1). 167-170
52. Payen D, Quintin L, Plaisance P, Chiron B, Lhoste F.. Head injury: clonidine decreases plasma catecholamines. Crit Care Med. 1990 ; 18 (4). 392-395 (Pubitemid 20138317)
53. Kariya N, Shindoh M, Nishi S, Yukioka H, Asada A.. Oral clonidine to control hypertension after head injury. Eur J Emerg Med. 1999 ; 6 (1). 77-79
54. Ter Minassian A, Beydon L, Decq P, Bonnet F.. Changes in cerebral hemodynamics after a single dose of clonidine in severely head-injured patients. Anesth Analg. 1997 ; 84 (1). 127-132 (Pubitemid 27020972)
55. Aryan HE, Box KW, Ibrahim D, Desiraju U, Ames CP.. Safety and efficacy of dexmedetomidine in neurosurgical patients. Brain Inj. 2006 ; 20 (8). 791-798 (Pubitemid 44594159)
56. Asgeirsson B, Grande PO, Nordstrom CH.. A new therapy of post-trauma brain oedema based on haemodynamic principles for brain volume regulation. Intensive Care Med. 1994 ; 20 (4). 260-267 (Pubitemid 24132365)
57. Eker C, Asgeirsson B, Grande PO, Schalen W, Nordstrom CH.. Improved outcome after severe head injury with a new therapy'based on principles for brain volume regulation and preserved microcirculation. Crit Care Med. 1998 ; 26 (11). 1881-1886 (Pubitemid 28527702)
58. Naredi S, Eden E, Zall S, Stephensen H, Rydenhag B.. A standardized neurosurgical neurointensive therapy directed toward vasogenic edema after severe traumatic brain injury: clinical results. Intensive Care Med. 1998 ; 24 (5). 446-451 (Pubitemid 28274156)
59. Grande PO, Asgeirsson B, Nordstrom CH.. Volume-targeted therapy of increased intracranial pressure: the Lund concept unifies surgical and non-surgical treatments. Acta Anaesthesiol Scand. 2002 ; 46 (8). 929-941 (Pubitemid 34953676)
60. Paalzow G, Paalzow L.. Clonidine antinociceptive activity: effects of drugs influencing central monoaminergic and cholinergic mechanisms in the rat. Naunyn Schmiedebergs Arch Pharmacol. 1976 ; 292 (2). 119-126
61. Skingle M, Hayes AG, Tyers MB.. Antinociceptive activity of clonidine in the mouse, rat and dog. Life Sci. 1982 ; 31 (11). 1123-1132 (Pubitemid 13243114)
62. Marwaha J, Kehne JH, Commisaris RL, Lakovski J, Shaw W, Davis M.. Spinal clonidine inhibits neural firing in locus coeruleus. Brain Res. 1983 ; 276 (2). 379-382
63. Kauppila T, Kemppainen P, Tanila H, Pertovaara A.. Effect of systemic medetomidine, an alpha-2 adrenoceptor agonist, on experimental pain in humans. Anesthesiology. 1991 ; 74 (1). 3-8
64. Ghignone M, Quintin L, Duke PC, Kehler CH, Calvillo O.. Effects of clonidine on narcotic requirements and hemodynamic response during induction of fentanyl anesthesia and endotracheal intubation. Anesthesiology. 1986 ; 64 (1). 36-42 (Pubitemid 16186770)
65. Ghignone M, Calvillo O, Quintin L.. Anesthesia and hypertension: the effect of clonidine on perioperative hemodynamics and isoflurane requirements. Anesthesiology. 1987 ; 67 (1). 3-10 (Pubitemid 18003420)
66. Ghignone M, Noe C, Calvillo O, Quintin L.. Anesthesia for ophthalmic surgery in the elderly: the effects of clonidine on intraocular pressure, perioperative hemodynamics and anesthetic requirements. Anesthesiology. 1988 ; 68 (5). 707-716
67. De Kock M, Wiederkehr P, Laghmiche A, Scholtes J-L.. Epidural clonidine used as the sole analgesic agent during and after abdominal surgery. Anesthesiology. 1997 ; 86 (2). 285-292 (Pubitemid 27093372)
68. Ramsay MA, Luterman DL.. Dexmedetomidine as a total intravenous anesthetic agent. Anesthesiology. 2004 ; 101 (3). 787-790 (Pubitemid 39121659)
69. Hofer RE, Sprung J, Sarr MG, Wedel DJ.. Anesthesia for a patient with morbid obesity using dexmedetomidine without narcotics. Can J Anaesth. 2005 ; 52 (2). 176-180 (Pubitemid 40467976)
70. Ramsay MA, Saha D, Hebeler RF.. Tracheal resection in the morbidly obese patient: the role of dexmedetomidine. J Clin Anesth. 2006 ; 18 (6). 452-454 (Pubitemid 44354096)
71. Voituron N, Kinkead R, Quintin L, Hilaire G. International Symposium on Respiratory Control. Saint-Maximin: France ; 2008 :
72. Bolme P, Fuxe K.. Pharmacological studies on a possible role of central noradrenaline neurons in respiratory control. J Pharm Pharmacol. 1973 ; 25 (4). 351-352
73. Bolme P, Corrodi H, Fuxe K, Hokfelt T, Lidbrink P, Goldstein M.. Possible involvement of central adrenaline neurons in vasomotor and respiratory control. Studies with clonidine and its interactions with piperoxane and yohimbine. Eur J Pharmacol. 1974 ; 28 (1). 89-94
74. Furst SR, Weinger MB.. Dexmedetomidine, a selective alpha 2-agonist, does not potentiate the cardiorespiratory depression of alfentanil in the rat. Anesthesiology. 1990 ; 72 (5). 882-888 (Pubitemid 20149225)
75. Bailey PL, Speng RJ, Johnson GK, et al. Respiratory effects of clonidine alone and combined with morphine in humans. Anesthesiology. 1991 ; 74 (1). 43-48
76. Ooi R, Pattison J, Feldman SA.. The effects of intravenous clonidine on ventilation. Anaesthesia. 1991 ; 46 (8). 632-633
77. Takahashi H, Nishikawa T, Mizutani T, Handa F.. Oral clonidine premedication decreases energy expenditure in human volunteers. Can J Anaesth. 1997 ; 44 (3). 268-272 (Pubitemid 27298897)
78. Quintin L, Viale JP, Annat G, et al. Oxygen uptake after major abdominal surgery: effect of clonidine. Anesthesiology. 1991 ; 74 (2). 236-241
79. Pawlik MT, Hansen E, Waldhauser D, Selig C, Kuehnel TS.. Clonidine premedication in patients with sleep apnea syndrome: a randomized, double-blind, placebo-controlled study. Anesth Analg. 2005 ; 101 (5). 1374-1380 (Pubitemid 41531874)
80. Bhatt J, Primhak R, Mayer A. Eur Respir Soc. 2005: P638.
81. Lindgren BR, Ekstrom T, Andersson RGG.. The effects of inhaled clonidine in patients with asthma. Am Rev Resp Dis. 1986 ; 134: 266-269 (Pubitemid 16046907)
82. Dinh Xuan AT, Lockhart A.. Bronchial effects of alpha-2 adrenoceptor agonists and of other antihypertensive agents in asthma. Am J Med. 1989 ; 87: 34S - 37S (Pubitemid 19248366)
83. Groeben H, Mitzner W, Brown RH.. Effects of the alpha-2 adrenoceptor agonist dexmedetomidine on bronchoconstriction in dogs. Anesthesiology. 2004 ; 100: 359-363 (Pubitemid 38133704)
84. Tobias JD, Berkenbosch JW, Russo P.. Additional experience with dexmedetomidine in pediatric patients. South Med J. 2003 ; 96 (9). 871-875 (Pubitemid 38279587)
85. Arpino PA, Kalafatas K, Thompson BT.. Feasibility of dexmedetomidine in facilitating extubation in the intensive care unit. J'Clin Pharm Ther. 2008 ; 33 (1). 25-30
86. Kobinger W, Pichler L.. The central modulatory effect of clonidine on the cardiodepressor reflex after suppression of synthesis and storage of noradrenaline. Eur J Pharmacol. 1975 ; 30 (1). 56-62
87. Haeusler G.. Clonidine-induced inhibition of sympathetic nerve'activity: no indication for a central presynaptic or an indirect sympathomimetic mode of action. Naunyn. 1974 ; 286: 97-111
88. Mermet C, Quintin L.. Effect of clonidine on the catechol metabolism in the rostral ventrolateral medulla: an in vivo electrochemical study. Eur J Pharmacol. 1991 ; 204 (1). 105-107
89. Guyenet P.. Is the hypotensive effect of clonidine and related drugs due to imidazoline binding sites?. Am J Physiol. 1997 ; 273 (5 Pt 2). R1580 - R1584
90. Bousquet P, Feldman J, Schwartz J.. Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines. J Pharmacol Exp Ther. 1984 ; 230 (1). 232-236 (Pubitemid 14097683)
91. Gillon JY, Quintin L, Ghignone M, Pujol JF.. Clonidine modulates the ventrolateral medullary catechol metabolic hyperactivity induced by hypotension. Brain Res. 1987 ; 418 (1). 157-163 (Pubitemid 17155595)
92. Heusch G, Schipke J, Thamer V.. Clonidine prevents the sympathetic initiation and aggravation of poststenotic myocardial ischemia. J Cardiovasc Pharmacol. 1985 ; 7 (6). 1176-1182 (Pubitemid 16180100)
93. Lawrence CJ, Prinzen FW, de LS.. The effect of dexmedetomidine on the balance of myocardial energy requirement and oxygen supply and demand. Anesth Analg. 1996 ; 82 (3). 544-550 (Pubitemid 26072959)
94. Motz W, Ippisch R, Strauer BE.. The role of clonidine in hypertensive heart disease. Influence on myocardial contractility and left ventricular afterload. Chest. 1983 ; 83 (suppl 2). 433-435 (Pubitemid 13153350)
95. Giles TD, Iteld BJ, Mautner RK, Rognoni PA, Dillenkoffer RL.. Short-term effects of intravenous clonidine in congestive heart failure. Clin Pharmacol Ther. 1981 ; 30 (6). 724-728 (Pubitemid 12198094)
96. Hermiller JB, Magorien RD, Leithe ME, Unverferth DV, Leier CV.. Clonidine in congestive heart failure: a vasodilator with negative inotropic effects. Am J Cardiol. 1983 ; 51 (5). 791-795 (Pubitemid 13141971)
97. Manolis AJ, Olympios C, Sifaki M, et al. Suppressing sympathetic activation in congestive heart failure: a new therapeutic strategy. Hypertension. 1995 ; 26 (5). 719-724
98. Olivari MT, Levine TB, Cohn JN.. Acute hemodynamic and hormonal effects of central vs. peripheral sympathetic inhibition in patients with congestive heart failure. J Cardiovasc Pharmacol. 1986 ; 8 (5). 973-978
99. Flacke JW, Flacke WE.. Clonidine prevention of myocardial ischemia during cardiac surgery: will this change outcome ?. J Cardiothorac Vasc Anesth. 1993 ; 7 (4). 383-385 (Pubitemid 23231388)
100. Giles TD, Thomas MG, Quiroz A, Rice JC, Plauche W, Sander GE.. Acute and short-term effects of clonidine in heart failure. Angiology. 1987 ; 38 (7). 537-548 (Pubitemid 17134416)
101. Foresti A, Massari FM, Lotto A.. Hemodynamic effects of clonidine in patients with acute myocardial infarction complicated by hypertension. J Cardiovasc Pharmacol. 1986 ; 8 (suppl 3). S30 - S32
102. Mitrovic V, Hallier E, Kuschke HJ.. The hemodynamic effects of clonidine in patients with grade III to IV hypertension. J Cardiovasc Pharmacol. 1986 ; 8 (suppl 3). S51 - S55
103. Northam WJ, Mobley P.. Clonidine pretreatment enhances the sensitivity of the beta-noradrenergic receptor coupled adenylate cyclase system in astrocytes. Eur J Pharmacol. 1985 ; 113 (1). 153-154 (Pubitemid 15246200)
104. Zoukos Y, Thomaides T, Pavitt DV, Leonard JP, Cuzner ML, Mathias CJ.. Upregulation of beta adrenoceptors on circulating mononuclear cells after reduction of central sympathetic outflow by clonidine in normal subjects. Clin Auton Res. 1992 ; 2: 165-170
105. Quiroz AC, Eilen SD, Sander GE, Giles TD.. The effect of intravenous clonidine hydrochloride on the isolated forearm venous segment in heart failure. Chest. 1983 ; 83 (suppl 2). 430-433 (Pubitemid 13153349)
106. Guthrie GP, Kotchen TA.. Effects of oral clonidine on baroreflex function in patients with essential hypertension. Chest. 1983 ; 83 (suppl 2). 327-328 (Pubitemid 13153311)
107. Dollery CT, Harington M, Hodge JV.. Haemodynamic studies with methyldopa: effect on cardiac output and response to pressor amines. Br Heart J. 1963 ; 25: 670-676
108. Parlow J, Sagnard P, Begou G, Viale JP, Quintin L.. The effects of clonidine on sensitivity to phenylephrine and nitroprusside in patients with essential hypertension recovering from surgery. Anesth Analg. 1999 ; 88 (6). 1239-1243 (Pubitemid 29246933)
109. Quintin L, Bouilloc X, Butin E, et al. Clonidine for aortic surgery in hypertensive patients: a double blind controlled randomized study. Anesth Analg. 1996 ; 83: 687-695 (Pubitemid 26349199)
110. De Kock M, Laterre PF, Van Obbergh L, Carlier M, Lerut J.. The effects of intraoperative intravenous clonidine on fluid requirements, hemodynamic variables, and support during liver transplantation: a prospective, randomized study. Anesth Analg. 1998 ; 86 (3). 468-476 (Pubitemid 28119401)
111. Herr DL, Sum-Ping ST, England M.. ICU sedation after coronary artery bypass graft surgery: dexmedetomidine-based versus propofol-based sedation regimens. J Cardiothorac Vasc Anesth. 2003 ; 17 (5). 576-584 (Pubitemid 37296621)
112. Pandharipande PP, Sanders RD, Girard TD, et al. Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial. Crit Care. 2010 ; 14 (2). R38
113. Dodd-o JM, Breslow MJ, Dorman T, Rosenfeld BA.. Preserved sympathetic response to hypotension despite perioperative alpha-2 agonist administration. Anesth Analg. 1997 ; 84 (6). 1208-1210 (Pubitemid 27250459)
114. Pichot C, Mathern P, Khettab F, Ghignone M, Geloen A, Quintin L.. Increased pressor response to noradrenaline during septic shock following clonidine?. Anesthesia Intensive Care (Sydney). 2010 ; 38: 734-735
115. Tobias JD.. Bradycardia during dexmedetomidine and therapeutic hypothermia. J Intensive Care Med. 2008 ; 23: 403-408
116. Pohl-Schickinger A, Lemmer J, Hubler M, et al. Intravenous clonidine infusion in infants after cardiovascular surgery. Paediatr Anaesth. 2008 ; 18 (3). 217-222 (Pubitemid 351159911)
117. Arenas-Lopez S, Riphagen S, Tibby SM, et al. Use of oral clonidine for sedation in ventilated paediatric intensive care patients. Intensive Care Med. 2004 ; 30 (8). 1625-1629 (Pubitemid 39094965)
118. Czaja AS, Zimmerman JJ.. The use of dexmedetomidine in critically ill children. Pediatr Crit Care Med. 2009 ; 10 (3). 381-386
119. Gerlach AT, Dasta JF, Steinberg S, Martin LC, Cook CH.. A new dosing protocol reduces dexmedetomidine-associated hypotension in critically ill surgical patients. J Crit Care. 2009 ; 24 (4). 568-574
120. Jorden VS, Pousman RM, Sanford MM, Thorborg PA, Hutchens MP.. Dexmedetomidine overdose in the perioperative setting. Ann Pharmacother. 2004 ; 38 (5). 803-807 (Pubitemid 38509057)
121. Meyer C, Cambray R.. One hundred times the intended dose of caudal clonidine in three pediatric patients. Paediatr Anaesth. 2008 ; 18 (9). 888-890
122. Erkonen G, Lamb F, Tobias JD.. High-dose dexmedetomidine-induced hypertension in a child with traumatic brain injury. Neurocrit Care. 2008 ; 9 (3). 366-369
123. Harron DW, Kobinger W.. Facilitation of the Bezold-Jarisch reflex by central stimulation of alpha-2 adrenoceptors in dogs. Naunyn Schmiedebergs Arch Pharmacol. 1984 ; 325 (3). 193-197 (Pubitemid 14142494)
124. Clementy J, Castagne D, Wicker P, Dallochio M, Bricaud H.. Study of the electrophysiologic properties of clonidine administered intravenously. J Cardiovasc Pharmacol. 1986 ; 8 (suppl 8). S24 - S29
125. Schwartz E, Friedman E, Mouallem M, Farfel Z.. Sinus arrest associated with clonidine therapy. Clin Cardiol. 1988 ; 11 (1). 53-54 (Pubitemid 18032096)
126. Ingersoll-Weng E, Manecke GR, Thistlethwaite PA.. Dexmedetomidine and cardiac arrest. Anesthesiology. 2004 ; 100 (3). 738-739 (Pubitemid 38268898)
127. Roulot D, Moreau R, Gaudin C, et al. Long-term sympathetic and hemodynamic responses to clonidine in patients with cirrhosis and ascites. Gastroenterology. 1992 ; 102 (4 Pt 1). 1309-1318
128. Arndts D.. New aspects of the clinical pharmacology of clonidine. Chest. 1983 ; 83 (suppl 2). 397-400 (Pubitemid 13153337)
129. Lenaerts A, Codden T, Meunier JC, Henry JP, Ligny G.. Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system. Hepatology. 2006 ; 44 (4). 844-849 (Pubitemid 46489547)
130. Esler M, Dudley F, Jennings G, et al. Increased sympathetic nervous activity and the effects of its inhibition with clonidine in alcoholic cirrhosis. Ann Intern Med. 1992 ; 116 (6). 446-455
131. Rubinoff MJ, Piccione PR, Holt PR.. Clonidine prolongs human small intestine transit time: use of the lactulose-breath hydrogen test. Am J Gastroenterol. 1989 ; 84 (4). 372-374 (Pubitemid 19106397)
132. Morali GA, Braverman DZ, Lissi J, Goldstein R, Jacobsohn WZ.. Effect of clonidine on gallbladder contraction and small bowel transit time in insulin-treated diabetics. Am J Gastroenterol. 1991 ; 86 (8). 995-999
133. Bear R, Steer K.. Pseudo-obstruction due to clonidine. Br Med J. 1976 ; 1 (6003). 197
134. Stieger DS, Cantieni R, Frutiger A.. Acute colonic pseudoobstruction (Ogilvie's syndrome) in two patients receiving high dose clonidine for delirium tremens. Intensive Care Med. 1997 ; 23 (7). 780-782 (Pubitemid 27379927)
135. Hamaya Y, Nishikawa T, Dohi S.. Diuretic effect of clonidine during isoflurane-nitrous oxide and oxygen anesthesia. Anesthesiology. 1994 ; 81 (4). 811-819 (Pubitemid 24332613)
136. Liepert DJ, Townsend GE.. Improved hemodynamic and renal function with clonidine in coronary artery bypass grafting. Anesth Analg. 1990 ; 70: S240
137. Kulka PJ, Tryba M, Zenz M.. Preoperative alpha-2 adrenergic receptor agonists prevent the deterioration of renal function after cardiac surgery: results of a randomized, controlled trial. Crit Care Med. 1996 ; 24: 947-952 (Pubitemid 26189934)
138. De Wolf AM, Fragen RJ, Avram MJ, Fitzgerald PC, Rahimi-Danesh F.. The pharmacokinetics of dexmedetomidine in volunteers with severe renal impairment. Anesth Analg. 2001 ; 93 (5). 1205-1209 (Pubitemid 33021018)
139. Hoffmann BB, Lefkowitz RJ. Goodmans and Gilman's The pharmacological Basis of Therapeutics. Hardman JG Limbird LE, ed. New York: McGraw-Hill ; 1996: 199-248.
140. Venn RM, Karol MD, Grounds RM.. Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive care. Br J Anaesth. 2002 ; 88 (5). 669-675 (Pubitemid 34498595)
141. Mertes N, Goeters C, Kuhmann M, Zander JF.. Postoperative alpha-2 adrenergic stimulation attenuates protein catabolism. Anesth Analg. 1996 ; 82 (2). 258-263
142. Kulka PJ, Tryba M, Reimer T, Weisser H.. Clonidine prevents tissue-malperfusion during extracorporal circulation. Anesth Analg. 1996 ; 83: 482-487
143. von Dossow V, Baehr N, Moshirzadeh M, et al. Clonidine attenuated early proinflammatory response in T-cell subsets after cardiac surgery. Anesth Analg. 2006 ; 103 (4). 809-814 (Pubitemid 44576676)
144. Hofer S, Steppan J, Wagner T, et al. Central sympatholytics prolong survival in experimental sepsis. Crit Care. 2009 ; 13 (1). R11
145. Taniguchi T, Kidani Y, Kanakura H, Takemoto Y, Yamamoto K.. Effects of dexmedetomidine on mortality rate and inflammatory response to endotoxin-induced shock in rats. Crit Care Med. 2004 ; 32 (6). 1322-1326 (Pubitemid 38738587)
146. Taniguchi T, Kurita A, Kobayashi K, Yamamoto K, Inaba H.. Dose- and time-related effects of dexmedetomidine on mortality and inflammatory responses to endotoxin-induced shock in rats. J Anesth. 2008 ; 22 (3). 221-228
147. Venn RM, Bryant A, Hall GM, Grounds RM.. Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in post-operative patients needing sedation in the intensive care unit. Br J Anaesth. 2001 ; 86 (5). 650-656 (Pubitemid 32409406)
148. Wunsch H, Kress JP.. A new era for sedation in ICU patients. J Am Med Assoc. 2009 ; 301 (5). 542-544
149. Esmaoglu A, Ulgey A, Akin A, Boyaci A.. Comparison between dexmedetomidine and midazolam for sedation of eclampsia patients in the intensive care unit. J Crit Care. 2009 ; 24 (4). 551-555
150. Oliver MF, Goldman L, Julian DG, Holme I.. Effect of mivazerol on perioperative cardiac complications during non-cardiac surgery in patients with coronary disease. Anesthesiology. 1999 ; 91 (4). 951-961 (Pubitemid 29466529)
151. Wallace AW, Galindez D, Salalieh A, et al. Effect of clonidine on cardiovascular morbidity and mortality after noncardiac surgery. Anesthesiology. 2004 ; 101 (2). 284-293 (Pubitemid 38988482)
152. Wijeysundera DN, Naik JS, Beattie S.. Alpha-2 adrenergic agonists to prevent cardiovascular complications. Am J Med. 2003 ; 114: 752
153. Stevens RD, Burri H, Tramer MR.. Pharmacologic myocardial protection in patients undergoing noncardiac surgery: a quantitative systematic review. Anesth Analg. 2003 ; 97 (3). 623-633 (Pubitemid 37046418)
154. Gregorakos L, Kerezoudi E, Dimopoulos G, Thomaides T.. Management of blood pressure instability in severe tetanus: the use of clonidine. Intensive Care Med. 1997 ; 23 (8). 893-895 (Pubitemid 27417695)
155. Tracey KJ.. The inflammatory reflex. Nature. 2002 ; 420 (6917). 853-859 (Pubitemid 36019638)
156. Miles BA, Lafuse WP, Zwilling BS.. Binding of alpha-adrenergic receptors stimulates the anti-mycobacterial activity of murine peritoneal macrophages. J Neuroimmunol. 1996 ; 71 (1-2). 19-24 (Pubitemid 26413251)
157. Shelly MP.. Dexmedetomidine: a real innovation or more of the same?. Br J Anaesth. 2001 ; 87: 677-678 (Pubitemid 33069553)